Woehrer Adelheid, Hainfellner Johannes A
Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
CNS Oncol. 2015;4(5):295-306. doi: 10.2217/cns.15.28. Epub 2015 Nov 6.
Several morphology- and polymerase chain reaction (PCR)-based methods for chromosome 1p 19q deletion status assessment are available. Important prerequisites for all molecular techniques concern tissue quality and selection of regions of interest. The most common methods for diagnostic 1p 19q assessment are fluorescence in situ hybridization and PCR-based microsatellite analysis. While the latter requires the use of autologous blood samples, more advanced techniques such as array comparative genomic hybridization, multiplex ligation-dependent probe amplification or real-time PCR are independent from autologous DNA samples. However, due to high technical demand and experience required their applicability as diagnostic tests remains to be shown. On the other hand, chromogenic in situ hybridization evolves as attractive alternative to FISH. Herein, the available test methods are reviewed and outlined, their advantages and drawbacks being discussed in detail.
目前有几种基于形态学和聚合酶链反应(PCR)的方法可用于评估1p 19q染色体缺失状态。所有分子技术的重要前提条件都涉及组织质量和感兴趣区域的选择。诊断1p 19q评估最常用的方法是荧光原位杂交和基于PCR的微卫星分析。虽然后者需要使用自体血样,但更先进的技术,如阵列比较基因组杂交、多重连接依赖探针扩增或实时PCR则不依赖于自体DNA样本。然而,由于其对技术要求高且需要经验,其作为诊断测试的适用性仍有待证明。另一方面,显色原位杂交逐渐成为荧光原位杂交的有吸引力的替代方法。本文对现有的检测方法进行了综述和概述,并详细讨论了它们的优缺点。